Melanoma-associated antigen 12; MAGE-12
CAT No: ta-480
Synonyms/Alias:Melanoma-associated antigen 12 (170-178); MAGE-12 (170-178)
MAGE-12 (170-178) is a synthetic peptide corresponding to amino acids 170 through 178 of the Melanoma Antigen Gene-12 (MAGE-12) protein, a member of the MAGE family known for its restricted expression in various tumors and limited presence in normal tissues. As a defined peptide fragment, it serves as a valuable molecular tool for exploring antigenic epitopes and immune recognition mechanisms, particularly in the context of tumor immunology and cancer antigen research. Its sequence specificity and functional relevance make it an important resource for investigators seeking to dissect the biological roles of MAGE antigens and their interactions with cellular components, especially within immunological and oncological research frameworks.
Epitope Mapping: Researchers frequently utilize the MAGE-12 (170-178) peptide for detailed epitope mapping studies, aiming to identify and characterize immunologically active regions within the MAGE-12 protein. By employing this defined peptide in binding assays or T cell activation experiments, investigators can pinpoint the precise amino acid sequences responsible for eliciting immune responses. Such work is foundational in understanding how cytotoxic T lymphocytes recognize tumor-associated antigens, providing critical insights into antigen processing and presentation pathways.
Immunogenicity Assessment: In the context of cancer immunology, this peptide is instrumental in evaluating the immunogenic potential of MAGE-12-derived epitopes. By incorporating the sequence into in vitro assays, scientists can assess T cell reactivity, cytokine release, and the functional avidity of antigen-specific lymphocytes. These studies inform the selection of promising peptide candidates for further investigation in immune monitoring protocols or experimental vaccine design, supporting the broader goal of developing targeted immunotherapeutic strategies.
Assay Development: The defined nature of MAGE-12 (170-178) allows it to serve as a standard or positive control in the development and validation of immunological assays, such as enzyme-linked immunospot (ELISPOT), flow cytometry-based intracellular cytokine staining, or peptide-MHC tetramer assays. Its inclusion in these platforms enables robust assessment of assay sensitivity, specificity, and reproducibility when detecting MAGE-12-specific immune responses. This application is essential for laboratories establishing reliable methodologies for monitoring antigen-specific T cell populations.
Peptide-Based Mechanistic Studies: Beyond immunological applications, the peptide is a useful probe for investigating fundamental aspects of peptide processing, antigen presentation, and MHC binding dynamics. By examining how this fragment is processed and presented by various HLA molecules, researchers can elucidate the structural and functional determinants of peptide-MHC interactions. Such mechanistic studies are vital for advancing understanding of antigen selection and presentation in both physiological and pathological contexts.
Biochemical Tool for Structure-Function Analysis: MAGE-12 (170-178) also supports structure-function analyses, where its defined sequence can be employed in studies of protein-protein interactions, peptide stability, or conformational dynamics. By serving as a model system, it enables the dissection of sequence-specific properties that influence antigenicity, peptide folding, or molecular recognition. These investigations contribute to a deeper understanding of the biophysical and biochemical principles governing tumor antigen behavior and their implications for immune surveillance.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.